[{"edinetCode":"E00981","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":145.0,"averageTemporaryStaff":5.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":3480793.0,"sharesOwendPercent":0.2057,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":18.76,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2017\/6\/23","stockCode":4565,"accountingYear":"第27期(自　2016年4月1日　至　2017年3月31日)","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00981","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":36777,"settlementDate":"2022\/12\/31","submitterName":"そーせいグループ株式会社","submitterNameEnglish":"Sosei Group Corporation","submitterNameKana":"ソーセイグループカブシキガイシャ","location":"千代田区麹町２丁目１番地","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E00981","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":152.0,"averageTemporaryStaff":2.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":4834942.0,"sharesOwendPercent":0.2537,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2018\/6\/22","stockCode":4565,"accountingYear":"第28期(自　2017年4月1日　至　2018年3月31日)","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00981","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":36777,"settlementDate":"2022\/12\/31","submitterName":"そーせいグループ株式会社","submitterNameEnglish":"Sosei Group Corporation","submitterNameKana":"ソーセイグループカブシキガイシャ","location":"千代田区麹町２丁目１番地","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E00981","endDate":"2018\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":169.0,"averageTemporaryStaff":12.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":17071324.0,"sharesOwendPercent":0.2237,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2019\/3\/28","stockCode":4565,"accountingYear":"第29期(自　2018年４月１日　至　2018年12月31日)","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2018\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00981","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":36777,"settlementDate":"2022\/12\/31","submitterName":"そーせいグループ株式会社","submitterNameEnglish":"Sosei Group Corporation","submitterNameKana":"ソーセイグループカブシキガイシャ","location":"千代田区麹町２丁目１番地","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E00981","endDate":"2019\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/5\/14","stockCode":4565,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00981","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":36777,"settlementDate":"2022\/12\/31","submitterName":"そーせいグループ株式会社","submitterNameEnglish":"Sosei Group Corporation","submitterNameKana":"ソーセイグループカブシキガイシャ","location":"千代田区麹町２丁目１番地","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E00981","endDate":"2019\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":21009701.0,"sharesOwendPercent":0.2748,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q2r","submitDate":"2019\/8\/13","stockCode":4565,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00981","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":36777,"settlementDate":"2022\/12\/31","submitterName":"そーせいグループ株式会社","submitterNameEnglish":"Sosei Group Corporation","submitterNameKana":"ソーセイグループカブシキガイシャ","location":"千代田区麹町２丁目１番地","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E00981","endDate":"2019\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2019\/11\/12","stockCode":4565,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00981","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":36777,"settlementDate":"2022\/12\/31","submitterName":"そーせいグループ株式会社","submitterNameEnglish":"Sosei Group Corporation","submitterNameKana":"ソーセイグループカブシキガイシャ","location":"千代田区麹町２丁目１番地","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E00981","endDate":"2019\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":163.0,"averageTemporaryStaff":11.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":21009770.0,"sharesOwendPercent":0.2726,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":56680000000.0,"currentAssets":19563000000.0,"fixedAsset":null,"tangibleFixedAssets":4120000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":11602000000.0,"currentLiabilities":2303000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":37479000000.0,"capitalSurplus":26548000000.0,"accumulatedEarnings":-12264000000.0,"treasuryStock":0.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":851000000.0,"grossProfit":null,"sgaExpenses":3614000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":116.1,"roe":null,"cashFlowFromOperatingActivities":3441000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-246000000.0,"cashFlowFromFinancialActivities":-6964000000.0,"changesInCashAndCashEquivalents":-3385000000.0,"列1":"asr","submitDate":"2020\/3\/25","stockCode":4565,"accountingYear":"第30期(自　2019年１月１日　至　2019年12月31日)","accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00981","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":36777,"settlementDate":"2022\/12\/31","submitterName":"そーせいグループ株式会社","submitterNameEnglish":"Sosei Group Corporation","submitterNameKana":"ソーセイグループカブシキガイシャ","location":"千代田区麹町２丁目１番地","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E00981","endDate":"2020\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":52864000000.0,"currentAssets":18398000000.0,"fixedAsset":null,"tangibleFixedAssets":3752000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":10639000000.0,"currentLiabilities":1737000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":37518000000.0,"capitalSurplus":26675000000.0,"accumulatedEarnings":-13010000000.0,"treasuryStock":0.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":175000000.0,"grossProfit":null,"sgaExpenses":783000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":1469000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":198000000.0,"cashFlowFromFinancialActivities":-211000000.0,"changesInCashAndCashEquivalents":960000000.0,"列1":"q1r","submitDate":"2020\/5\/13","stockCode":4565,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00981","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":36777,"settlementDate":"2022\/12\/31","submitterName":"そーせいグループ株式会社","submitterNameEnglish":"Sosei Group Corporation","submitterNameKana":"ソーセイグループカブシキガイシャ","location":"千代田区麹町２丁目１番地","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E00981","endDate":"2020\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":22544093.0,"sharesOwendPercent":0.2918,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":51078000000.0,"currentAssets":18016000000.0,"fixedAsset":null,"tangibleFixedAssets":3604000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":10139000000.0,"currentLiabilities":2236000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":37662000000.0,"capitalSurplus":26819000000.0,"accumulatedEarnings":-14381000000.0,"treasuryStock":0.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":333000000.0,"grossProfit":null,"sgaExpenses":1661000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":1057000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-387000000.0,"cashFlowFromFinancialActivities":-148000000.0,"changesInCashAndCashEquivalents":-13000000.0,"列1":"q2r","submitDate":"2020\/8\/13","stockCode":4565,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00981","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":36777,"settlementDate":"2022\/12\/31","submitterName":"そーせいグループ株式会社","submitterNameEnglish":"Sosei Group Corporation","submitterNameKana":"ソーセイグループカブシキガイシャ","location":"千代田区麹町２丁目１番地","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E00981","endDate":"2020\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":73322000000.0,"currentAssets":39876000000.0,"fixedAsset":null,"tangibleFixedAssets":3795000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":25092000000.0,"currentLiabilities":2240000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":40211000000.0,"capitalSurplus":30290000000.0,"accumulatedEarnings":-13906000000.0,"treasuryStock":0.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":531000000.0,"grossProfit":null,"sgaExpenses":2475000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":2232000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-109000000.0,"cashFlowFromFinancialActivities":20678000000.0,"changesInCashAndCashEquivalents":22425000000.0,"列1":"q3r","submitDate":"2020\/11\/11","stockCode":4565,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00981","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":36777,"settlementDate":"2022\/12\/31","submitterName":"そーせいグループ株式会社","submitterNameEnglish":"Sosei Group Corporation","submitterNameKana":"ソーセイグループカブシキガイシャ","location":"千代田区麹町２丁目１番地","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E00981","endDate":"2020\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":190.0,"averageTemporaryStaff":12.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":24697827.0,"sharesOwendPercent":0.3065,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":76465000000.0,"currentAssets":42018000000.0,"fixedAsset":null,"tangibleFixedAssets":3824000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":24084000000.0,"currentLiabilities":2985000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":40220000000.0,"capitalSurplus":30452000000.0,"accumulatedEarnings":-10785000000.0,"treasuryStock":0.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":761000000.0,"grossProfit":null,"sgaExpenses":3435000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":95.9,"roe":null,"cashFlowFromOperatingActivities":4672000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-150000000.0,"cashFlowFromFinancialActivities":20278000000.0,"changesInCashAndCashEquivalents":24633000000.0,"列1":"asr","submitDate":"2021\/3\/24","stockCode":4565,"accountingYear":"第31期(自　2020年１月１日　至　2020年12月31日)","accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00981","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":36777,"settlementDate":"2022\/12\/31","submitterName":"そーせいグループ株式会社","submitterNameEnglish":"Sosei Group Corporation","submitterNameKana":"ソーセイグループカブシキガイシャ","location":"千代田区麹町２丁目１番地","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E00981","endDate":"2021\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":79373000000.0,"currentAssets":42565000000.0,"fixedAsset":null,"tangibleFixedAssets":4012000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":24356000000.0,"currentLiabilities":3238000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":40421000000.0,"capitalSurplus":30659000000.0,"accumulatedEarnings":-11938000000.0,"treasuryStock":0.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":226000000.0,"grossProfit":null,"sgaExpenses":975000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-890000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-62000000.0,"cashFlowFromFinancialActivities":197000000.0,"changesInCashAndCashEquivalents":388000000.0,"列1":"q1r","submitDate":"2021\/5\/12","stockCode":4565,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00981","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":36777,"settlementDate":"2022\/12\/31","submitterName":"そーせいグループ株式会社","submitterNameEnglish":"Sosei Group Corporation","submitterNameKana":"ソーセイグループカブシキガイシャ","location":"千代田区麹町２丁目１番地","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E00981","endDate":"2021\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":26493899.0,"sharesOwendPercent":0.3255,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":81348000000.0,"currentAssets":42908000000.0,"fixedAsset":null,"tangibleFixedAssets":3915000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":25592000000.0,"currentLiabilities":4176000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":40909000000.0,"capitalSurplus":30696000000.0,"accumulatedEarnings":-13082000000.0,"treasuryStock":0.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":447000000.0,"grossProfit":null,"sgaExpenses":1934000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-1475000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":410000000.0,"cashFlowFromFinancialActivities":451000000.0,"changesInCashAndCashEquivalents":621000000.0,"列1":"q2r","submitDate":"2021\/8\/12","stockCode":4565,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00981","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":36777,"settlementDate":"2022\/12\/31","submitterName":"そーせいグループ株式会社","submitterNameEnglish":"Sosei Group Corporation","submitterNameKana":"ソーセイグループカブシキガイシャ","location":"千代田区麹町２丁目１番地","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E00981","endDate":"2021\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":88956000000.0,"currentAssets":51816000000.0,"fixedAsset":null,"tangibleFixedAssets":3752000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":35183000000.0,"currentLiabilities":3778000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":41036000000.0,"capitalSurplus":28934000000.0,"accumulatedEarnings":-12610000000.0,"treasuryStock":0.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":638000000.0,"grossProfit":null,"sgaExpenses":2888000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-2888000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":379000000.0,"cashFlowFromFinancialActivities":11191000000.0,"changesInCashAndCashEquivalents":9833000000.0,"列1":"q3r","submitDate":"2021\/11\/11","stockCode":4565,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00981","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":36777,"settlementDate":"2022\/12\/31","submitterName":"そーせいグループ株式会社","submitterNameEnglish":"Sosei Group Corporation","submitterNameKana":"ソーセイグループカブシキガイシャ","location":"千代田区麹町２丁目１番地","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E00981","endDate":"2021\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":198.0,"averageTemporaryStaff":11.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":26253873.0,"sharesOwendPercent":0.3219,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":96985000000.0,"currentAssets":62808000000.0,"fixedAsset":null,"tangibleFixedAssets":3817000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":39517000000.0,"currentLiabilities":7191000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":41036000000.0,"capitalSurplus":29100000000.0,"accumulatedEarnings":-9768000000.0,"treasuryStock":0.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":933000000.0,"grossProfit":null,"sgaExpenses":3940000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":151.96,"roe":null,"cashFlowFromOperatingActivities":7095000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":278000000.0,"cashFlowFromFinancialActivities":11123000000.0,"changesInCashAndCashEquivalents":20079000000.0,"列1":"asr","submitDate":"2022\/3\/24","stockCode":4565,"accountingYear":"第32期(自　2021年１月１日　至　2021年12月31日)","accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00981","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":36777,"settlementDate":"2022\/12\/31","submitterName":"そーせいグループ株式会社","submitterNameEnglish":"Sosei Group Corporation","submitterNameKana":"ソーセイグループカブシキガイシャ","location":"千代田区麹町２丁目１番地","industory":"医薬品","corporateNumber":4010000000000.0}]